{"ORPHApacket":[{"ORPHApacketID":"100057","date":"2019-12-05 21:46:03","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"100057","Name":[{"lang":"en","label":"Renin-angiotensin-aldosterone system-blocker-induced angioedema"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_100057","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Acquired angioedema"}],"ORPHA":"91385","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_91385"},{"Name":[{"lang":"en","label":"Disease associated with a genetic susceptibility or tested for a biomarker"}],"ORPHA":"231957","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_231957"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE, see this term) characterized by acute edema in subcutaneous tissues, viscera and\/or the upper airway."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"300909","DisorderMappingRelation":[{"id":"21541","Name":[{"lang":"en","label":"BTNT (broader term maps to a narrower term)"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Multigenic\/multifactorial"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"8","Synonym":[{"lang":"en","label":"ACE inhibitor-related acquired angioedema"},{"lang":"en","label":"ACEI-related acquired angioedema"},{"lang":"en","label":"Acquired angioedema with normal C1 inhibitor"},{"lang":"en","label":"Acquired angioedema with normal C1INH"},{"lang":"en","label":"RAAS-blocker-induced angioedema"},{"lang":"en","label":"RAAS-blocker-induced angioneurotic edema"},{"lang":"en","label":"RAE"},{"lang":"en","label":"Renin-angiotensin-aldosterone system-blocker-induced angioneurotic edema"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"X-prolyl aminopeptidase 2"}],"Symbol":"XPNPEP2","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"12823"},{"Source":"OMIM","Reference":"300145"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317345","Name":[{"lang":"en","label":"Major susceptibility factor in"}]}]}]}]}]}